64798-36-3Relevant academic research and scientific papers
NOVEL COMPOUNDS FOR THE TREATMENT OF CYSTIC FIBROSIS
-
Paragraph 00182, (2014/12/12)
The present invention is directed to novel compounds, pharmaceutical compositions comprising such compounds, and the methods of making and using the same. These compounds are useful as modulators of Cystic Fibrosis Transmembrane Conductor Regulator (CFTR). The present invention also relates to methods of treating or lessening the severity of cystic fibrosis in a patient. These compounds may be used alone or in combination with one or more secondary active agents.
NAPHTHALENONE COMPOUNDS EXHIBITING PROLYL HYDROXYLASE INHIBITORY ACTIVITY, COMPOSITIONS, AND USES THEREOF
-
, (2008/12/06)
Compounds of Formula (I) and Formula (II) are useful as inhibitors of HIF prolyl hydroxylases. Compounds of Formula(I) and Formula (II) have the following structures, where the definitions of the variables are provided herein.
3-(α,α-Dimethylbenzyl)urea compounds, compositions, and their use as herbicides
-
, (2008/06/13)
A compound of the general formula (I): STR1 wherein X is halogen or trifluoromethyl, n and m are 0 or 1, R1 is lower C1 - C2 alkyl or C1 - C2 alkoxy and R2 is C4 - C5
